Objectives: 

The purpose of this study was to identify patients with glaucoma and corneal/ocular surface disease who have been fit with Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE; BostonSight, Needham, MA) devices and to understand the PROSE device fit experience in patients with glaucoma at Weill Cornell Medicine (WCM).

Methods: 

This is a retrospective chart review of patients older than 18 years who underwent PROSE device fitting at WCM. Records were reviewed for demographic information and ophthalmic variables. Descriptive statistics were performed.

Results: 

Between 2011 and 2017, 281 patients underwent PROSE device fitting at WCM, of whom 24 patients (8.5%) had a glaucoma diagnosis and 17 patients (6.0%) were identified as glaucoma suspect. Ocular surface disease was the most common indication for PROSE device wear (58.3%). Five patients had a history of incisional glaucoma surgery in the eye undergoing PROSE device fitting: three valved glaucoma drainage implants and two trabeculectomies. Three of these eyes were successfully fit with PROSE devices.

Conclusions: 

Patients fitted with Prosthetic Replacement of the Ocular Surface Ecosystem devices at WCM had a higher prevalence of glaucoma than in the general population. Among patients with incisional glaucoma surgery, PROSE device fitting was challenging, with a 40% failure rate.

中文翻译：

---

青光眼患病率和青光眼手术考虑在眼表生态系统设备使用的假体置换中

目标： 

本研究的目的是确定患有青光眼和角膜/眼表疾病的患者，这些患者已适合眼表生态系统假体置换（PROSE；BostonSight，Needham，MA）设备，并了解 PROSE 设备适合患有眼表生态系统的患者的体验。 Weill Cornell Medicine (WCM) 的青光眼。

方法： 

这是对在 WCM 接受 PROSE 装置验配的 18 岁以上患者的回顾性图表回顾。审查了人口统计信息和眼科变量的记录。进行了描述性统计。

结果： 

2011 年至 2017 年间，281 名患者在 WCM 接受了 PROSE 设备验配，其中 24 名患者（8.5%）被诊断为青光眼，17 名患者（6.0%）被确定为青光眼疑似患者。眼表疾病是 PROSE 设备磨损的最常见指征（58.3%）。5 名患者有接受 PROSE 装置安装的眼部青光眼切口手术史：3 名带瓣的青光眼引流植入物和 2 名小梁切除术。其中三只眼睛成功地适应了 PROSE 设备。

结论： 

在 WCM 安装了眼表生态系统修复装置的患者，其青光眼患病率高于普通人群。在青光眼切口手术患者中，PROSE 装置的安装具有挑战性，失败率为 40%。